EXJADE Side Effects

6985034-5 | Pulmonary Embolism
on Sep 03, 2010 Female patient from UNITED KINGDOM , 50 years of age, was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). Exjade dosage: 20 Mg/kg, Qd.

6985007-2 | Acute Chest Syndrome, Pulmonary Hypertension
Patient was taking Exjade (View Usage). Patient had the following side effects: acute chest syndrome, pulmonary hypertension (What is pulmonary hypertension?) on Sep 02, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 143.5 lb, was diagnosed with sickle cell anaemia, cerebrovascular accident, pregnancy (What is pregnancy?) and. Exjade dosage: 1500 Mg, Qd. During the same period patient was treated with HYDROXYUREA (1500 Mg, Daily) (View Hydroxyurea Review and Hydroxyurea Label ), ASPIRIN (81 Mg, Daily) (View Aspirin Review and Aspirin Label ), XOPENEX (1-2 Puff Every 4hours Prn) (View Xopenex Review and Xopenex Label ), FOLIC ACID (1 Mg) (View Folic Acid Review and Folic Acid Label ), PRENATAL VITAMINS (Unk) (View Prenatal Vitamins Review and Prenatal Vitamins Label ). Patient was hospitalized.

6985005-9 | Anaemia, Blood Creatinine Increased, Creatinine Renal Clearance Decreased, Facial Bones Fracture, Fall, Fractured Sacrum, Laceration, Leukopenia, Rib Fracture
Adverse event was reported on Sep 02, 2010 by a Female patient taking Exjade (View Usage) (Dosage: 1500 Mg/day) was diagnosed with haemosiderosis, myelodysplastic syndrome and. Location: GERMANY , weighting 132.3 lb, After Exjade was administered, patient had the following side effects: anaemia, blood creatinine increased, creatinine renal clearance decreased, facial bones fracture, fall (What is fall?), fractured sacrum, laceration, leukopenia, rib fracture. During the same period patient was treated with LENALIDOMIDE (5 Mg, Qd) (View Lenalidomide Review and Lenalidomide Label ), REVLIMID (5 Mg) (View Revlimid Review and Revlimid Label ). Patient was hospitalized.

6984342-1 | Acute Myeloid Leukaemia, Malignant Neoplasm Progression
on Sep 08, 2010 Male patient from UNITED STATES , weighting 101.4 lb, was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, malignant neoplasm progression. Exjade dosage: 1000 Mg, Qd.


6984324-X | Transplant
on Sep 01, 2010 Female patient from UNITED STATES , weighting 120.0 lb, was diagnosed with sickle cell anaemia and was treated with Exjade (View Usage). Patient had the following side effects: transplant. Exjade dosage: 1000 Mg, Daily.

6984321-4 | Bone Marrow Transplant
Patient was taking Exjade (View Usage). After Exjade was administered, patient had the following side effects: bone marrow transplant (What is bone marrow transplant?) on Sep 01, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 185.0 lb, was diagnosed with sickle cell anaemia and. Exjade dosage: 1500 Mg, Qd. Patient was hospitalized.

6980569-3 | Cardiac Arrest, Lung Infection, Mucormycosis, Pneumonia, Pyrexia
Adverse event was reported on Sep 09, 2010 by a Male patient taking Exjade (View Usage) (Dosage: Unk) was diagnosed with myelodysplastic syndrome and. Location: JAPAN , 68 years of age, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), lung infection, mucormycosis, pneumonia (What is pneumonia?), pyrexia. During the same period patient was treated with BLOOD TRANSFUSION, AUXILIARY PRODUCTS (View Blood Transfusion, Auxiliary Products Review and Blood Transfusion, Auxiliary Products Label ).

6980561-9 |
on Sep 09, 2010 Female patient from UNITED STATES , weighting 235.5 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Exjade (View Usage). . Exjade dosage: 1500 Mg, Qd.

6980555-3 | Blood Albumin Decreased, Blood Bilirubin Increased, Blood Calcium Decreased, Blood Potassium Decreased, Carbon Dioxide Decreased, Extramedullary Haemopoiesis, Fibrosis, Haemosiderosis, Hepatic Failure
on Sep 08, 2010 Male patient from UNITED STATES , weighting 132.3 lb, was diagnosed with sickle cell anaemia and was treated with Exjade (View Usage). After Exjade was administered, patient had the following side effects: blood albumin decreased, blood bilirubin increased, blood calcium decreased, blood potassium decreased, carbon dioxide decreased, extramedullary haemopoiesis, fibrosis, haemosiderosis, hepatic failure. Exjade dosage: 875 Mg, Qd. During the same period patient was treated with PENICILLIN (250 Mg, Bid) (View Penicillin Review and Penicillin Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized and became disabled.

6980518-8 | Pain
Patient was taking Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: pain (What is pain?) on Sep 01, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 149.9 lb, was diagnosed with sickle cell anaemia with crisis, pain (What is pain?) and. Exjade dosage: 2000 Mg, Qd. During the same period patient was treated with PERCOCET (Q4-6 Pm) (View Percocet Review and Percocet Label ), PHENERGAN (Q6-8 Pm) (View Phenergan Review and Phenergan Label ), FOLIC ACID (Daily) (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6980514-0 | Haematuria, Infection, Nephrolithiasis, Thrombocytopenia
Adverse event was reported on Sep 01, 2010 by a Male patient taking Exjade (View Usage) (Dosage: 250 Mg, Tid) was diagnosed with iron overload, pain (What is pain?) and. Location: UNITED STATES , weighting 187.0 lb, Patient had the following side effects: haematuria, infection (What is infection?), nephrolithiasis, thrombocytopenia. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

6980497-3 | Acute Myeloid Leukaemia, Anaemia, Blast Cell Count Increased, Bone Marrow Reticulin Fibrosis, Eosinophilia, Hepatic Failure, Leukopenia, Malignant Neoplasm Progression, Marrow Hyperplasia
on Sep 01, 2010 Male patient from UNITED STATES , weighting 159.0 lb, was diagnosed with thalassaemia, haemochromatosis and was treated with Exjade (View Usage). After Exjade was administered, patient had the following side effects: acute myeloid leukaemia, anaemia, blast cell count increased, bone marrow reticulin fibrosis, eosinophilia, hepatic failure, leukopenia, malignant neoplasm progression, marrow hyperplasia. Exjade dosage: 1500 Mg, Qd. During the same period patient was treated with LOTREL (View Lotrel Review and Lotrel Label ), PLAVIX (View Plavix Review and Plavix Label ), SOTALOL (View Sotalol Review and Sotalol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).

6979155-0 | Nausea, Prostate Cancer Metastatic
on Sep 09, 2010 Male patient from UNITED STATES , weighting 205.0 lb, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?), prostate cancer metastatic. Exjade dosage: 2000 Mg, Daily.

6978348-6 | Blood Count Abnormal, Decreased Appetite, Fluid Retention, Renal Pain, Splenomegaly, Weight Decreased
Patient was taking Exjade (View Usage). Patient had the following side effects: blood count abnormal, decreased appetite, fluid retention, renal pain, splenomegaly, weight decreased on Aug 31, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 222.4 lb, was diagnosed with myelodysplastic syndrome and. Exjade dosage: 1500 Mg Daily. During the same period patient was treated with REVLIMID (15 Mg Twice Weekly) (View Revlimid Review and Revlimid Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), TRANSFUSIONS (View Transfusions Review and Transfusions Label ). Patient was hospitalized.

6977940-2 | Pneumonia
Adverse event was reported on Sep 07, 2010 by a Female patient taking Exjade (View Usage) (Dosage: 250 Mg Daily) was diagnosed with neoplasm and. Location: UNITED STATES , weighting 122.0 lb, After Exjade was administered, patient had the following side effects: pneumonia (What is pneumonia?).

6977935-9 | Dermatitis Allergic, Erythema
on Aug 31, 2010 Female patient from AUSTRALIA , weighting 127.9 lb, was diagnosed with iron overload and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis allergic, erythema. Exjade dosage: 1000 Mg, Qd.

6977933-5 | Malaise
on Aug 30, 2010 Female patient from UNITED STATES , weighting 125.0 lb, was diagnosed with iron overload and was treated with Exjade (View Usage). Patient had the following side effects: malaise. Exjade dosage: 1000 Mg, Qd.

6977929-3 | Acute Chest Syndrome, Pulmonary Hypertension
Patient was taking Exjade (View Usage). After Exjade was administered, patient had the following side effects: acute chest syndrome, pulmonary hypertension (What is pulmonary hypertension?) on Aug 30, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 143.5 lb, was diagnosed with sickle cell anaemia and. Exjade dosage: 1500 Mg, Qd. During the same period patient was treated with HYDROXYUREA (1500 Mg, Daily) (View Hydroxyurea Review and Hydroxyurea Label ), ASPIRIN (81 Mg, Daily) (View Aspirin Review and Aspirin Label ), XOPENEX (Unk) (View Xopenex Review and Xopenex Label ).

6975922-8 | Gastric Disorder, Serum Ferritin Increased
Adverse event was reported on Aug 27, 2010 by a Male patient taking Exjade (View Usage) (Dosage: 1500 Mg, Qd) . Location: UNITED STATES , weighting 170.2 lb, Patient experienced the following unwanted or unexpected effects: gastric disorder, serum ferritin increased. Patient was hospitalized.

6973302-2 |
on Sep 07, 2010 Male patient from UNITED STATES , weighting 160.9 lb, was diagnosed with plasmacytoma and was treated with Exjade (View Usage). . Exjade dosage: 500 Mg, Tid.

6973298-3 | Neutrophil Count Decreased, Platelet Count Decreased
on Sep 07, 2010 Male patient from UNITED STATES , weighting 213.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Exjade (View Usage). After Exjade was administered, patient had the following side effects: neutrophil count decreased, platelet count decreased. Exjade dosage: 2500 Mg Daily. During the same period patient was treated with ACETYLSALICYLIC ACID (Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CARBIDOPA + LEVODOPA (View Carbidopa + Levodopa Review and Carbidopa + Levodopa Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), FIBERCON (POLYCARBOPHIL CALCIUM) (View Fibercon (polycarbophil Calcium) Review and Fibercon (polycarbophil Calcium) Label ), CENTRUM (View Centrum Review and Centrum Label ), DOXYCYCLINE (Unk) (View Doxycycline Review and Doxycycline Label ). Patient was hospitalized.

6973292-2 | Abdominal Pain, Diarrhoea, Pruritus
Patient was taking Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), diarrhoea, pruritus on Sep 03, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 182.0 lb, was diagnosed with iron overload, pruritus, oedema, pain (What is pain?) and. Exjade dosage: 1250 Mg, Daily. During the same period patient was treated with BENADRYL (Unk) (View Benadryl Review and Benadryl Label ), LASIX (40 / Daily) (View Lasix Review and Lasix Label ), SPIRONOLACTONE (50 / B.i.d.) (View Spironolactone Review and Spironolactone Label ), VICODIN ES (Unk) (View Vicodin Es Review and Vicodin Es Label ).

6972312-9 | Sepsis
Adverse event was reported on Sep 03, 2010 by a Male patient taking Exjade (View Usage) (Dosage: 2000 Mg/daily) was diagnosed with neoplasm and. Location: UNITED STATES , weighting 152.0 lb, Patient had the following side effects: sepsis (What is sepsis?).

6972306-3 | Abdominal Pain Upper, Eye Swelling, Fluid Retention, Muscle Spasms, Nausea, Oedema Peripheral, Swelling Face, Weight Increased
on Aug 27, 2010 Female patient from GERMANY , weighting 130.1 lb, was diagnosed with thalassaemia beta, prophylaxis against gastrointestinal ulcer, tachycardia, thrombosis prophylaxis, platelet count increased and was treated with Exjade (View Usage). After Exjade was administered, patient had the following side effects: abdominal pain upper, eye swelling, fluid retention, muscle spasms, nausea (What is nausea?), oedema peripheral, swelling face, weight increased. Exjade dosage: 1750 Mg/day. During the same period patient was treated with NEXIUM (20 Mg/day) (View Nexium Review and Nexium Label ), DILTIAZEM (180 Mg/day) (View Diltiazem Review and Diltiazem Label ), MARCUMAR (As Needed (quick)) (View Marcumar Review and Marcumar Label ), ASPIRIN (100 Mg/day) (View Aspirin Review and Aspirin Label ), HYDROXYUREA (View Hydroxyurea Review and Hydroxyurea Label ).

6972297-5 | Arterial Graft, Carotid Artery Disease, Dyspnoea, Fatigue
on Aug 26, 2010 Female patient from UNITED STATES , weighting 140.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: arterial graft, carotid artery disease (What is carotid artery disease?), dyspnoea, fatigue. Exjade dosage: 625 Mg, Qd.

6970620-9 |
Patient was taking Exjade (View Usage). on Sep 03, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 162.0 lb, was diagnosed with myelodysplastic syndrome and. Exjade dosage: 1500 Mg, Qd.

6969887-2 | Anaemia, Blood Albumin Decreased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Glucose Increased, Blood Sodium Decreased, Blood Urea Increased, Dyspnoea, Fatigue
Adverse event was reported on Sep 01, 2010 by a Male patient taking Exjade (View Usage) (Dosage: ) was diagnosed with anxiety (What is anxiety?) and. Location: UNITED STATES , weighting 175.3 lb, After Exjade was administered, patient had the following side effects: anaemia, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood glucose increased, blood sodium decreased, blood urea increased, dyspnoea, fatigue. During the same period patient was treated with XOLAIR (View Xolair Review and Xolair Label ), MAXZIDE (Unk) (View Maxzide Review and Maxzide Label ), ASPIRIN (81 Mg/daily) (View Aspirin Review and Aspirin Label ), ATIVAN (Unk) (View Ativan Review and Ativan Label ).

6967396-8 | Pain
on Aug 25, 2010 Female patient from UNITED STATES , weighting 149.9 lb, was diagnosed with sickle cell anaemia with crisis and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: pain (What is pain?). Exjade dosage: 2000 Mg, Qd. Patient was hospitalized.

6967394-4 | Back Pain, Pneumonia
on Aug 25, 2010 Female patient from UNITED STATES , weighting 120.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Exjade (View Usage). Patient had the following side effects: back pain (What is back pain?), pneumonia (What is pneumonia?). Exjade dosage: 1125 Mg Daily. Patient was hospitalized.

6966915-5 | Cardiac Failure
Patient was taking Exjade (View Usage). After Exjade was administered, patient had the following side effects: cardiac failure on Sep 01, 2010 from MEXICO Additional patient health information: Female patient , 62 years of age, was diagnosed with iron overload, diabetes mellitus and. Exjade dosage: 2 Df, Qd. During the same period patient was treated with BI EUGLUCON (1/2 Tablet Daily) (View Bi-euglucon Review and Bi-euglucon Label ).

6966883-6 | Blood Albumin Decreased, Blood Bilirubin Increased, Blood Calcium Decreased, Blood Potassium Decreased, Carbon Dioxide Decreased, Extramedullary Haemopoiesis, Fibrosis, Haemosiderosis, Hepatic Failure
Adverse event was reported on Aug 31, 2010 by a Male patient taking Exjade (View Usage) (Dosage: 875 Mg, Qd) was diagnosed with iron overload, sickle cell anaemia and. Location: UNITED STATES , weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: blood albumin decreased, blood bilirubin increased, blood calcium decreased, blood potassium decreased, carbon dioxide decreased, extramedullary haemopoiesis, fibrosis, haemosiderosis, hepatic failure. During the same period patient was treated with PENICILLIN (250 Mg, Bid) (View Penicillin Review and Penicillin Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized and became disabled.

6966860-5 | Abdominal Discomfort, Activities Of Daily Living Impaired, Headache, Liver Transplant, Oropharyngeal Pain, Vertigo
on Aug 25, 2010 Female patient from UNITED STATES , weighting 156.5 lb, was treated with Exjade (View Usage). Patient had the following side effects: abdominal discomfort, activities of daily living impaired, headache (What is headache?), liver transplant (What is liver transplant?), oropharyngeal pain, vertigo. Exjade dosage: 1250 Mg, Qd.

6966110-X | Bladder Injury, Colon Injury, Diarrhoea, Ear Infection, Influenza, Nausea, Pain, Post Procedural Haemorrhage, Prostate Cancer
on Aug 24, 2010 Male patient from UNITED STATES , weighting 180.8 lb, was diagnosed with iron metabolism disorder and was treated with Exjade (View Usage). After Exjade was administered, patient had the following side effects: bladder injury, colon injury, diarrhoea, ear infection (What is ear infection?), influenza, nausea (What is nausea?), pain (What is pain?), post procedural haemorrhage, prostate cancer (What is prostate cancer?). Exjade dosage: 1500 Mg, Per Day. During the same period patient was treated with LEXAPRO (View Lexapro Review and Lexapro Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), KLONOPIN (View Klonopin Review and Klonopin Label ). Patient was hospitalized.

6965258-3 |
Patient was taking Exjade (View Usage). on Sep 01, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 235.5 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Exjade dosage: 1500 Mg, Qd.

6965248-0 | Abdominal Wall Operation, Blood Potassium Increased, Calcinosis, Dialysis, Diarrhoea, Dry Skin, Dysphagia, Headache, Muscle Tightness
Adverse event was reported on Aug 24, 2010 by a Female patient taking Exjade (View Usage) (Dosage: 1500 Mg, Qd) . Location: UNITED STATES , weighting 107.0 lb, Patient had the following side effects: abdominal wall operation, blood potassium increased, calcinosis, dialysis (What is dialysis?), diarrhoea, dry skin, dysphagia, headache (What is headache?), muscle tightness. Patient was hospitalized.

6965222-4 | Dizziness, Oxygen Saturation Decreased, Urinary Tract Infection
on Aug 23, 2010 Female patient from UNITED STATES , weighting 188.5 lb, was diagnosed with sickle cell anaemia and was treated with Exjade (View Usage). After Exjade was administered, patient had the following side effects: dizziness (What is dizziness?), oxygen saturation decreased, urinary tract infection (What is urinary tract infection?). Exjade dosage: 1500 Mg, Daily. Patient was hospitalized.

6965220-0 | Diarrhoea, Oedema, Pleural Effusion
on Aug 24, 2010 Male patient from GREECE , 81 years of age, was diagnosed with iron overload and was treated with Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, oedema, pleural effusion. Exjade dosage: 1500 Mg. During the same period patient was treated with SINTROM (View Sintrom Review and Sintrom Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FRUMIL (View Frumil Review and Frumil Label ), EXELON (View Exelon Review and Exelon Label ), PRETERAX (View Preterax Review and Preterax Label ).

6965215-7 | Confusional State
Patient was taking Exjade (View Usage). Patient had the following side effects: confusional state on Aug 23, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 88.99 lb, was diagnosed with iron metabolism disorder and. Exjade dosage: 2000 Mg, Qd.

6965213-3 | Dehydration, Oedema Peripheral
Adverse event was reported on Aug 24, 2010 by a Female patient taking Exjade (View Usage) (Dosage: 750 Mg, Daily) was diagnosed with iron metabolism disorder and. Location: UNITED STATES , weighting 84.00 lb, After Exjade was administered, patient had the following side effects: dehydration, oedema peripheral. During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), SINGULAIR (View Singulair Review and Singulair Label ), EVISTA (View Evista Review and Evista Label ), LASIX (View Lasix Review and Lasix Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ZOCOR (View Zocor Review and Zocor Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6964545-2 |
on Aug 31, 2010 Female patient from UNITED STATES , weighting 138.0 lb, was diagnosed with iron overload and was treated with Exjade (View Usage). . Exjade dosage: 1000 Mg, Daily.

6964536-1 | Cerebrovascular Accident, Hepatic Enzyme Increased, Surgery
on Aug 23, 2010 Male patient from UNITED STATES , weighting 55.34 lb, was diagnosed with sickle cell anaemia, iron overload and was treated with Exjade (View Usage). Patient had the following side effects: cerebrovascular accident, hepatic enzyme increased, surgery (What is surgery?). Exjade dosage: 500 Mg, Qd. Patient was hospitalized.

6960148-4 |
Patient was taking Exjade (View Usage). on Aug 30, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 83.78 lb, was diagnosed with myelodysplastic syndrome and. Exjade dosage: 750 Mg, Qd. During the same period patient was treated with OS CAL (View Os-cal Review and Os-cal Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6958807-2 |
Adverse event was reported on Aug 25, 2010 by a Male patient taking Exjade (View Usage) (Dosage: 1250 Mg, Daily) . Location: UNITED STATES , weighting 128.3 lb, .

6958792-3 | Diarrhoea, Pollakiuria
on Aug 19, 2010 Male patient from UNITED STATES , weighting 160.9 lb, was treated with Exjade (View Usage). Patient had the following side effects: diarrhoea, pollakiuria. Exjade dosage: 1000 Mg, Qd.

6958788-1 | Convulsion, Insomnia
on Aug 19, 2010 Male patient from FRANCE , 21 years of age, weighting 143.3 lb, was diagnosed with iron overload, haemochromatosis, epilepsy (What is epilepsy?) and was treated with Exjade (View Usage). After Exjade was administered, patient had the following side effects: convulsion, insomnia. Exjade dosage: 1500 Mg/day. During the same period patient was treated with TOPIRAMATE (100 Mg, Tid For 3 Years) (View Topiramate Review and Topiramate Label ).

6958758-3 | Diarrhoea, Fungal Skin Infection, Nausea, Rash, Renal Disorder
Patient was taking Exjade (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, fungal skin infection, nausea (What is nausea?), rash (What is rash?), renal disorder on Jul 23, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 246.9 lb, was diagnosed with aplastic anaemia and. Exjade dosage: 2000 Mg Daily (qpm). During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), FLOMAX (View Flomax Review and Flomax Label ), SENNOSIDES DOCUSATE (View Sennosides-docusate Review and Sennosides-docusate Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), ZOFRAN (8 Mg/day (qam)) (View Zofran Review and Zofran Label ).

6957576-X | Febrile Neutropenia, Syncope
Adverse event was reported on Aug 19, 2010 by a Female patient taking Exjade (View Usage) (Dosage: 250 Mg, Daily) was diagnosed with myelodysplastic syndrome and. Location: UNITED STATES , weighting 139.0 lb, Patient had the following side effects: febrile neutropenia, syncope. During the same period patient was treated with TYLENOL 500 (View Tylenol-500 Review and Tylenol-500 Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), CITRACAL (View Citracal Review and Citracal Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), CHONDROITIN (View Chondroitin Review and Chondroitin Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6957574-6 | Abdominal Discomfort, Activities Of Daily Living Impaired, Headache, Liver Transplant, Oropharyngeal Pain, Vertigo
on Aug 18, 2010 Female patient from UNITED STATES , weighting 156.5 lb, was treated with Exjade (View Usage). After Exjade was administered, patient had the following side effects: abdominal discomfort, activities of daily living impaired, headache (What is headache?), liver transplant (What is liver transplant?), oropharyngeal pain, vertigo. Exjade dosage: 1250 Mg, Qd.

6956793-2 |
on Aug 24, 2010 Female patient from UNITED STATES , weighting 83.78 lb, was diagnosed with myelodysplastic syndrome and was treated with Exjade (View Usage). . Exjade dosage: 750 Mg, Qd. During the same period patient was treated with OS CAL (View Os-cal Review and Os-cal Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6956729-4 | Activated Partial Thromboplastin Time Prolonged, Alanine Aminotransferase Increased, Altered State Of Consciousness, Anaemia, Aphasia, Aspartate Aminotransferase Increased, Basophil Count Increased, Blood Bilirubin Increased, Blood Glucose Increased
Patient was taking Exjade (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, altered state of consciousness, anaemia, aphasia (What is aphasia?), aspartate aminotransferase increased, basophil count increased, blood bilirubin increased, blood glucose increased on Aug 17, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 194.0 lb, was diagnosed with myelodysplastic syndrome, blood iron increased, hypertension and. Exjade dosage: 500 Mg/day. During the same period patient was treated with DECITABINE (View Decitabine Review and Decitabine Label ), LISINOPRIL (40 Mg/day) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.